Brief: Homology Medicines Reports Third Quarter 2022 Financial Results And Recent Highlights
10/11/2022 22:11
Nov 10 (Reuters) - Homology Medicines Inc FIXX.O :
* HOMOLOGY MEDICINES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
* HOMOLOGY MEDICINES INC - CASH RUNWAY EXPECTED INTO Q4 2024
* HOMOLOGY MEDICINES INC Q3 LOSS PER SHARE $0.59
Source text for Eikon: ID:nGNX4hxg2P
Further company coverage: FIXX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview